Nippon India Pharma Fund Direct IDCW
Summary Info
Fund Name
: Nippon India Mutual Fund
Scheme Name
: Nippon India Pharma Fund Direct IDCW
AMC
: Nippon India Mutual Fund
Type
: Open
Category
: Equity - Pharma
Launch Date
: 01-Jan-2013
Fund Manager
: Sailesh Raj Bhan
Net Assets (Rs. cr)
: 9044.23
Nippon India Pharma Fund Direct IDCW - Nav Details
Nav Date
: 13-Jul-2026
NAV [Rs.]
: 172.5201
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
:
Exit Load %
:
Nippon India Pharma Fund Direct IDCW- NAV Chart
Nippon India Pharma Fund Direct IDCW- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | -0.65 | 4.24 | 13.16 | 10.95 | 9.75 | 21.41 | 13.54 | 18.15 |
| Category Avg | 0.08 | 5.37 | 16.78 | 15.11 | 13.41 | 23.08 | 14.48 | 17.04 |
| Category Best | 1.74 | 7.1 | 21.43 | 23.26 | 21.89 | 26.92 | 17.56 | 31.45 |
| Category Worst | -0.72 | 4.17 | 10.01 | 5.62 | 4.64 | 18.9 | 10.85 | 5.23 |
Nippon India Pharma Fund Direct IDCW- Latest Dividends
Record DateDividend %Bonus
03-Feb-20261200
Nippon India Pharma Fund Direct IDCW- Investment Details
Min. Investment(Rs.)
: 5000
Increm.Investment(Rs.)
: 1000
In & Out
In
InName Of The CompanyNo Of Shares
Piramal Pharma55,00,000
Out
InName Of The CompanyNo Of Shares
--
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 12.78 | 6206349 | 1,155.93 |
| Equity | Lupin | Pharmaceuticals & Biotechnology | 7.45 | 2783991 | 673.44 |
| Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 6.68 | 4449746 | 603.87 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 6.15 | 3795054 | 556.12 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 5.46 | 750754 | 493.92 |
| Equity | Apollo Hospitals | Healthcare Services | 5.27 | 548795 | 476.46 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 4.03 | 1431195 | 364.32 |
| Equity | Sai Life | Pharmaceuticals & Biotechnology | 3.49 | 2555745 | 315.45 |
| Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 3.46 | 913918 | 312.80 |
| Equity | Max Healthcare | Healthcare Services | 3.32 | 2658082 | 300.16 |
| Equity | Medplus Health | Retailing | 3.18 | 3545229 | 287.42 |
| Equity | Vijaya Diagnost. | Healthcare Services | 2.80 | 1871618 | 253.15 |
| Equity | Thyrocare Tech. | Healthcare Services | 2.65 | 4366909 | 239.87 |
| Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 2.57 | 1364742 | 232.14 |
| Equity | Glaxosmi. Pharma | Pharmaceuticals & Biotechnology | 2.47 | 913226 | 223.76 |
| Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 2.21 | 800549 | 199.73 |
| Equity | Abbott India | Pharmaceuticals & Biotechnology | 2.09 | 74339 | 189.11 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 1.99 | 323678 | 180.28 |
| Equity | Dr Lal Pathlabs | Healthcare Services | 1.85 | 1018224 | 167.62 |
| Equity | Narayana Hrudaya | Healthcare Services | 1.80 | 823911 | 162.45 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 1.75 | 1002630 | 158.28 |
| Equity | Syngene Intl. | Healthcare Services | 1.70 | 3501497 | 153.89 |
| Equity | Pfizer | Pharmaceuticals & Biotechnology | 1.56 | 318249 | 141.28 |
| Equity | Emcure Pharma | Pharmaceuticals & Biotechnology | 1.52 | 746337 | 137.02 |
| Equity | Fortis Health. | Healthcare Services | 1.42 | 1346128 | 128.81 |
| Equity | Suraksha Diagno. | Healthcare Services | 1.18 | 3896349 | 106.35 |
| Equity | Sanofi Consumer | Pharmaceuticals & Biotechnology | 1.09 | 213659 | 98.21 |
| Equity | Akums Drugs | Pharmaceuticals & Biotechnology | 1.03 | 1489317 | 92.80 |
| Equity | Piramal Pharma | Pharmaceuticals & Biotechnology | 1.02 | 5500000 | 92.44 |
| Equity | Anthem Bioscienc | Pharmaceuticals & Biotechnology | 0.90 | 1058503 | 81.56 |
| Equity | Sanofi India | Pharmaceuticals & Biotechnology | 0.87 | 230272 | 78.43 |
| Equity | Biocon | Pharmaceuticals & Biotechnology | 0.68 | 1469374 | 61.46 |
| Equity | Astrazeneca Phar | Pharmaceuticals & Biotechnology | 0.57 | 62568 | 51.47 |
| Equity | Indoco Remedies | Pharmaceuticals & Biotechnology | 0.49 | 1834924 | 43.89 |
| Equity | Concord Biotech | Pharmaceuticals & Biotechnology | 0.16 | 111738 | 14.30 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
Nippon India Mutual Fund
Incorporation Date:
24-Feb-1995
Total Assets Managed (Cr.):
7,67,506.41
Trustee/s:
Nippon Life India Trustee
Chairman:
NA
CEO / MD:
Mr. Sundeep Sikka
CIO:
NA
President:
NA
Director/s:
Mr. Akira Shibata, Mr. Sushil C. Tripathi, Mr. Kazuhide Toda
Compliance Officer/s:
Mr. Muneesh Sud
Investor Service Officer/s:
Mr. Milind Nesarikar
Fund Manager/s:
Sailesh Raj Bhan
Auditors:
Haribhakti & Co LLP Chart
OTHER INFORMATION
Registered Office:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact Nos:
022-68087000/1860260111
Fax:
022-68087097
Website:
